3SQ1 Fundamental Analysis - AHT SYNGAS TECHNOLOGY NV

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to 3SQ1. 3SQ1 was compared to 45 industry peers in the Construction & Engineering industry. Both the profitability and financial health of 3SQ1 have multiple concerns. 3SQ1 is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year 3SQ1 has reported negative net income.

The reported net income has been mixed in the past 5 years: 3SQ1 reported negative net income in multiple years.

3SQ1 had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

3SQ1 has a Return On Assets of -22.27%. This is amonst the worse of the industry: 3SQ1 underperforms 97.78% of its industry peers.

3SQ1 has a Return On Equity of -53.96%. This is amonst the worse of the industry: 3SQ1 underperforms 95.56% of its industry peers.

		Industry Rank	Sector Rank
ROA	-22.27%
ROE	-53.96%
ROIC	N/A

ROA(3y)-8.05%

ROA(5y)-6.53%

ROE(3y)-16.29%

ROE(5y)-12.08%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

3SQ1 does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for 3SQ1 has been increased compared to 1 year ago.

3SQ1 has more shares outstanding than it did 5 years ago.

3SQ1 has a better debt/assets ratio than last year.

2.2 Solvency

3SQ1 has an Altman-Z score of -0.08. This is a bad value and indicates that 3SQ1 is not financially healthy and even has some risk of bankruptcy.

3SQ1's Altman-Z score of -0.08 is on the low side compared to the rest of the industry. 3SQ1 is outperformed by 95.56% of its industry peers.

A Debt/Equity ratio of 0.04 indicates that 3SQ1 is not too dependend on debt financing.

3SQ1's Debt to Equity ratio of 0.04 is amongst the best of the industry. 3SQ1 outperforms 95.56% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	-0.08

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

3SQ1 has a Current Ratio of 1.49. This is a normal value and indicates that 3SQ1 is financially healthy and should not expect problems in meeting its short term obligations.

3SQ1's Current ratio of 1.49 is fine compared to the rest of the industry. 3SQ1 outperforms 80.00% of its industry peers.

3SQ1 has a Quick Ratio of 1.27. This is a normal value and indicates that 3SQ1 is financially healthy and should not expect problems in meeting its short term obligations.

3SQ1 has a Quick ratio of 1.27. This is in the better half of the industry: 3SQ1 outperforms 73.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.49
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

3SQ1 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -381.25%.

Looking at the last year, 3SQ1 shows a very negative growth in Revenue. The Revenue has decreased by -30.64% in the last year.

Measured over the past years, 3SQ1 shows a very strong growth in Revenue. The Revenue has been growing by 52.65% on average per year.

EPS 1Y (TTM)-381.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-722.22%

Revenue 1Y (TTM)-30.64%

Revenue growth 3Y115.36%

Revenue growth 5Y52.65%

Sales Q2Q%-100%

3.2 Future

3SQ1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.22% yearly.

Based on estimates for the next years, 3SQ1 will show a very strong growth in Revenue. The Revenue will grow by 53.24% on average per year.

EPS Next Y74.49%

EPS Next 2Y43.92%

EPS Next 3Y41.9%

EPS Next 5Y45.22%

Revenue Next Year-14.23%

Revenue Next 2Y18.16%

Revenue Next 3Y39.66%

Revenue Next 5Y53.24%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

3SQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 3SQ1. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as 3SQ1's earnings are expected to grow with 41.90% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y43.92%

EPS Next 3Y41.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for 3SQ1!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AHT SYNGAS TECHNOLOGY NV

FRA:3SQ1 (12/4/2025, 7:00:00 PM)

2.96

+0.08 (+2.78%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryConstruction & Engineering

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners10.92%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap7.40M

Revenue(TTM)9.47M

Net Income(TTM)-2.45M

Analysts84

Price Target20.37 (588.18%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-4.15%

PT rev (3m)-2.08%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.78
P/FCF	N/A
P/OCF	N/A
P/B	1.75
P/tB	1.93
EV/EBITDA	N/A

EPS(TTM)-0.9

EYN/A

EPS(NY)-0.25

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS3.79

BVpS1.69

TBVpS1.54

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-22.27%
ROE	-53.96%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-8.05%

ROA(5y)-6.53%

ROE(3y)-16.29%

ROE(5y)-12.08%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.86

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.49
Quick Ratio	1.27
Altman-Z	-0.08

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-381.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-722.22%

EPS Next Y74.49%

EPS Next 2Y43.92%

EPS Next 3Y41.9%

EPS Next 5Y45.22%

Revenue 1Y (TTM)-30.64%

Revenue growth 3Y115.36%

Revenue growth 5Y52.65%

Sales Q2Q%-100%

Revenue Next Year-14.23%

Revenue Next 2Y18.16%

Revenue Next 3Y39.66%

Revenue Next 5Y53.24%

EBIT growth 1Y-361.9%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.31%

EBIT Next 3Y45.6%

EBIT Next 5Y47.06%

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

AHT SYNGAS TECHNOLOGY NV / 3SQ1.DE FAQ

What is the ChartMill fundamental rating of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to 3SQ1.DE.

What is the valuation status of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to AHT SYNGAS TECHNOLOGY NV (3SQ1.DE). This can be considered as Overvalued.

How profitable is AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) has a profitability rating of 0 / 10.

Can you provide the expected EPS growth for 3SQ1 stock?

The Earnings per Share (EPS) of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) is expected to grow by 74.49% in the next year.

AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AHT SYNGAS TECHNOLOGY NV / 3SQ1.DE FAQ

What is the ChartMill fundamental rating of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

What is the valuation status of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

How profitable is AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

Can you provide the expected EPS growth for 3SQ1 stock?